Considerations before initiating therapy in Parkinsonism: basing on the quality of life

Autor: Jian-Jun Wu, Zhen-Yang Liu, Cong Shen, Yu-Jie Du, Jue Zhao, Yi-Min Sun, Shu-Jin He, Feng-Tao Liu, Xin-Yue Zhou, Ke Yang, Yu-Jie Yang, Jian Wang
Rok vydání: 2019
Předmět:
Zdroj: Journal of Neurology. 266:3119-3125
ISSN: 1432-1459
0340-5354
DOI: 10.1007/s00415-019-09545-0
Popis: Improvement of quality-of-life (QoL) has been termed as a primary objective in initiating therapy in both Parkinson’s disease (PD) and multiple system atrophy Parkinsonian subtype (MSA-P). We aimed to compare the determinants of life quality in drug naive PD and MSA-P patients. Eighty-six drug-naive PD patients and thirty-five drug-naive MSA-P patients were included to explore the determinants of QoL. Demographic information, motor deficits, and non-motor symptoms were included in the clinical assessment. Both motor and non-motor functions were more severely impaired in the drug-naive MSA-P patients, with higher PDQ-39 scores indicating poorer QoL. Physical discomfort and stigma were the main affected sub-domains in PD, while mobility and activity of daily life were the main affected ones in MSA-P. BECK depressive scores and UPDRS-III scores were independent variables of PDQ-39 in MSA-P patients. Age, depression, disease stages and non-motor scores were independent variables of PDQ-39 in PD patients. Drug-naive MSA-P patients suffered from more severe motor and non-motor disability, as well as poorer QoL. Depression and non-motor symptoms were proved to be the most critical determinants for QoL in PD, while motor function was supposed to be the major determinant for MSA-P. When initiating therapy, physicians need to focus more on motor functions in drug-naive MSA-P patients, but on depression in PD patients.
Databáze: OpenAIRE
Externí odkaz: